Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic ...
In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...
Hosted on MSN
Researchers link CAR-T cell aging to cancer relapse
Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, or CAR-T cell therapy. Over time, the engineered immune ...
Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit harder. Called EchoBack CAR T-cells, these new cancer-fighting tools work ...
Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of outpatient CAR T-cell therapy treatment. Chimeric antigen receptor T-cell (CAR T) ...
The ZUMA-24 study showed outpatient axicabtagene ciloleucel (axi-cel) for DLBCL reduced hospitalization and improved safety profiles. CAR T-cell therapy for DLBCL shows promise in outpatient settings, ...
MedPage Today on MSN
CAR-T Drug for Myeloma Hit With New Boxed Warning
Ciltacabtagene autoleucel (cilta-cel; Carvykti) for multiple myeloma has a new boxed warning for immune effector ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, or CAR-T cell therapy. Over time, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback